---
title: "Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) Reaches Key Midpoint Milestone in Multiple Sclerosis Imaging Study"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/291174602.md"
description: "Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) Reaches Key Midpoint Milestone in Multiple Sclerosis Imaging Study"
datetime: "2026-06-29T17:00:41.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/291174602.md)
  - [en](https://longbridge.com/en/news/291174602.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/291174602.md)
generator: "portal-rs"
---

# Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) Reaches Key Midpoint Milestone in Multiple Sclerosis Imaging Study


### Related Stocks

- [QNTM.US](https://longbridge.com/en/quote/QNTM.US.md)

## Related News & Research

- [Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) Advances Myelin-Protecting MS Therapy as Treatment Paradigm Evolves](https://longbridge.com/en/news/296514765.md)
- [Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) Reports Lower Q2 Expenses, Advances Lucid-MS Into Phase 2](https://longbridge.com/en/news/296129489.md)
- [Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) Targets Disability Drivers Beyond Relapse Rates in Multiple Sclerosis](https://longbridge.com/en/news/295819977.md)
- [12:26 ETThe Multiple Sclerosis Association of America (MSAA) Recognizes Ten-Year Milestone of Online Support Platform, My MSAA Community](https://longbridge.com/en/news/296518219.md)
- [Optomed Oyj (HEL:OPTOMED) Second-Quarter Results: Here's What Analysts Are Forecasting For This Year](https://longbridge.com/en/news/296297835.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**